Quick articles of interest:
A quick update on the Pompe disease post I wrote a couple weeks ago.
The enzyme replacement therapy (Myozyme) I discussed previously decreases in effectiveness if the patient develops antigens to the enzyme. A small clinical trial found patients who receive a low dose of chemotherapy drugs decreased the immune response and improved the patients’ functioning.
Via one of my FB friends: USF Study links autism to abnormal immune characteristics, novel protein fragment. Researchers found a protein fragment in circulating blood at higher levels in an autistic mouse model compared to nonautistic mice. More testing needs to be done, but perhaps this could lead to a blood test for autism.
That’s all I’ve got for now. Have a good weekend!